HealthcareChief

HealthcareChief Leading online publication for healthcare industry executives

Provider credentialing is often a manual and time-consuming process, with each day a physician is unable to see patients...
09/20/2025

Provider credentialing is often a manual and time-consuming process, with each day a physician is unable to see patients translating into lost revenue for organisations. Credentialing a single provider typically takes between 90 to 120 days, and delays can cost $6,000 to $8,000 per provider monthly, according to some estimates. Startup Assured has identified this as an opportunity to use artificial intelligence to speed up provider credentialing, licensing, and payer enrolment.

Aegis Ventures has added three new members to its digital consortium, broadening the collaborative initiative to develop...
09/20/2025

Aegis Ventures has added three new members to its digital consortium, broadening the collaborative initiative to develop and scale artificial intelligence-powered health technology solutions. Yale New Haven Health System, Keck Medicine of USC, and Hartford HealthCare are the latest health systems to join, increasing the group’s reach to 14 members. Existing participants include Northwell Health, UPMC, Stanford Health Care, and Vanderbilt Health.

Aetna, a CVS Health subsidiary, is rolling out a new Medicare Advantage (MA) inpatient reimbursement policy that alters ...
09/20/2025

Aetna, a CVS Health subsidiary, is rolling out a new Medicare Advantage (MA) inpatient reimbursement policy that alters how hospitals are paid for urgent and emergency claims.

Abbott has received CE Mark approval in Europe for an expanded indication of its Navitor™ transcatheter aortic valve imp...
09/04/2025

Abbott has received CE Mark approval in Europe for an expanded indication of its Navitor™ transcatheter aortic valve implantation (TAVI) system. The device, which treats people with symptomatic, severe aortic stenosis, can now be used in patients at low or intermediate risk for open-heart surgery.

Berlin Heals Holding AG, a MedTech company based in Switzerland, is progressing the development of its implantable devic...
09/04/2025

Berlin Heals Holding AG, a MedTech company based in Switzerland, is progressing the development of its implantable device designed to reverse remodeling and aid recovery in heart failure patients.

Facing mounting pressure in the competition for next-generation obesity treatments, Novo Nordisk is turning to RNA-based...
09/02/2025

Facing mounting pressure in the competition for next-generation obesity treatments, Novo Nordisk is turning to RNA-based science to strengthen its early pipeline. The company has entered a multiyear alliance with Replicate Bioscience that could be valued at up to $550 million. It will provide Novo access to the firm’s platform to keep a close eye on cardiometabolic illness targets.

Amid uncertainty over how the Trump administration would handle COVID-19 vaccination policy for the upcoming respiratory...
09/02/2025

Amid uncertainty over how the Trump administration would handle COVID-19 vaccination policy for the upcoming respiratory virus season, the U.S. Food and Drug Administration (FDA) has approved updated vaccines from Pfizer, Moderna, and Novavax, but with significant usage limitations.

Halda Therapeutics has entered into a collaboration with VantAI in a deal valued at more than $1 billion. The agreement ...
08/23/2025

Halda Therapeutics has entered into a collaboration with VantAI in a deal valued at more than $1 billion. The agreement is structured around the use of VantAI’s machine learning and proteomics technologies to supply Halda with novel target-effector pairs that can be incorporated into its regulated induced proximity targeting chimeras (RIPTACs). These bifunctional small molecules are being developed to address cancer and immune-mediated diseases.

CSL plans to trim as much as 15% of its staff as part of a sweeping overhaul aimed at lowering R&D expenses and preparin...
08/22/2025

CSL plans to trim as much as 15% of its staff as part of a sweeping overhaul aimed at lowering R&D expenses and preparing a spinout of its vaccine arm.

In its full-year earnings report released today, the Melbourne-based company said it would shrink its fixed-cost base and boost pipeline efficiency by consolidating its R&D operations.

Novartis may have dropped one Sjögren’s syndrome program this year, but the pharmaceutical giant appears to have a promi...
08/16/2025

Novartis may have dropped one Sjögren’s syndrome program this year, but the pharmaceutical giant appears to have a promising contender with a different drug candidate. The Switzerland-based company has been testing ianalumab, a dual-action, B-cell-depleting antibody aimed at the BAFF-R protein, in two phase 3 trials named Neptunus 1 and 2, which together recruited 779 individuals with the systemic autoimmune disorder.

Cardinal Health revealed today that The Specialty Alliance, its platform for managing multi-specialty management service...
08/15/2025

Cardinal Health revealed today that The Specialty Alliance, its platform for managing multi-specialty management services (MSO), has finalized an agreement to purchase Solaris Health, recognized as the nation’s foremost urology MSO, from Lee Equity Partners along with the physician stakeholders of Solaris Health.

Germany-based CureVac and Britain-based GSK and BioNTech have ended a multi-year patent battle with Pfizer and its partn...
08/14/2025

Germany-based CureVac and Britain-based GSK and BioNTech have ended a multi-year patent battle with Pfizer and its partner BioNTech over mRNA vaccine technology, which was front and center in the global battle against COVID-19.

Address

Newark, NJ

Website

Alerts

Be the first to know and let us send you an email when HealthcareChief posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category